Bone mineral density and disease activity in untreated systemic lupus erythematosus patients

National Medical Journal of China

Volumn 92, Issue 33, 2012, Pages 2331-2334

  Zhang, Fang Ze ^a   Su, Mei Hua ^b   Li, Ping ^b  

^a JILIN UNIVERSITY   (China)

^b NONE

Author keywords

Bone density; Disease activity; Lupus erythematosus, systemic

Indexed keywords

GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT;

ARTICLE; BONE DENSITY; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE ACTIVITY; DISEASE DURATION; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR NECK; GREATER TROCHANTER; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUMBAR SPINE; MAJOR CLINICAL STUDY; PREMENOPAUSE; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC LUPUS ERYTHEMATOSUS DISEASE ACTIVITY INDEX;

EID: 84869227991     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2012.33.008     Document Type: Article

References (14)

1. Mok C C, Wong S N, Ma K M. Childhood-onset disease carries a higher risk of low bone mineral density in an adult population of systemic lupus erythematosus. Rheumatology, 2012, 51: 468-475.
2. 2004, 8: 92-96.
3. Alele J D, Kamen D L, Hunt K J, et al. Bone geometry profiles in women with and without SLE. J Bone Miner Res, 2011, 26(11): 2719-2726.
4. Redlich K, Ziegler S, Kiener H P, et al. Bone mineral density and biochemical parameters of bone metabolism in female patients with systemic lupus erythematosus. Ann Rheum Dis, 2000, 59: 308-310.
5. Mendoza-Pinto C, García-Carrasco M, Sandoval-Cruz H. Risks factors for low bone mineral density in pre-menopausal Mexican women with systemic lupus erythematosus. Clin Rheumatol, 2009, 28: 65-70.
6. Boyanov M, Robeva R, Popivanov P. Bone mineral density changes in women with systemic lupus erythematosus. Clin Rheumatol, 2003, 22: 318-323.
7. Jardinet D, Lefèbvre C, Depresseux G, et al. Longitudinal analysis of bone mineral density in pre-menopausal female systemic lupus erythematosus patients: deleterious role of glucocorticoid therapy at the lumbar spine. Rheumatology, 2000, 39: 389-392.
8. Furukawa M, Kiyohara C, Tsukamoto H, et al. Prevalence of and risk factors for low bone mineral density in Japanese female patients with systemic lupus erythematosus. Rheumatol Int, 2011, 31: 365-376.
9. Schmajuk G, Yelin E, Chakravarty E, et al. Osteoporosis screening, prevention, and treatment in systemic lupus erythematosus: application of the systemic lupus erythematosus quality indicators. Arthritis Care Res, 2010, 62: 993-1001.
10. Yeap S S, Fauzi A R, Kong N C, et al. Influences on bone mineral density in Malaysian premenopausal systemic lupus erythematosus patients on corticosteroids. Lupus, 2009, 18: 178-181.
11. Chong H C, Chee S S, Goh E M, et al. Dietary calcium and bone mineral density in premenopausal women with systemic lupus erythematosus. Clin Rheumatol, 2007, 26: 182-185.
12. Alele J D, Kamen D L. The importance of inflammation and vitamin D status in SLE-associated osteoporosis. Autoimmun Rev, 2010, 9: 137-139.
13. Yeap S S, Othman A Z, Zain A A, et al. Vitamin D levels: its relationship to bone mineral density response and disease activity in premenopausal Malaysian systemic lupus erythematosus patients on corticosteroids. Int J Rheum Dis, 2012, 15: 17-24.
14. Kamen D L, Cooper G S, Bouali H, et al. Vitamin D deficiency in systemic lupus erythematosus. Autoimmun Rev, 2006, 5: 114-117.